Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment.
Eicosanoids are bioactive lipid mediators derived from arachidonic acid(1) (AA), which is released by cytosolic phospholipase A2 (cPLA2). AA is metabolized through three major pathways, cyclooxygenase (COX), lipoxygenase (LO) and cytochrome P450, to produce a family of eicosanoids, which individuall...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3823604?pdf=render |
id |
doaj-44a507f3fab74c2cb8b7f8b5518861b5 |
---|---|
record_format |
Article |
spelling |
doaj-44a507f3fab74c2cb8b7f8b5518861b52020-11-25T01:46:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e7963310.1371/journal.pone.0079633Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment.Joanna M PoczobuttMiguel GijonJay AminDwight HansonHoward LiDeandra WalkerMary Weiser-EvansXian LuRobert C MurphyRaphael A NemenoffEicosanoids are bioactive lipid mediators derived from arachidonic acid(1) (AA), which is released by cytosolic phospholipase A2 (cPLA2). AA is metabolized through three major pathways, cyclooxygenase (COX), lipoxygenase (LO) and cytochrome P450, to produce a family of eicosanoids, which individually have been shown to have pro- or anti-tumorigenic activities in cancer. However, cancer progression likely depends on complex changes in multiple eicosanoids produced by cancer cells and by tumor microenvironment and a systematic examination of the spectrum of eicosanoids in cancer has not been performed. We used liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) to quantitate eicosanoids produced during lung tumor progression in an orthotopic immunocompetent mouse model of lung cancer, in which Lewis lung carcinoma (LLC) cells are injected into lungs of syngeneic mice. The presence of tumor increased products of both the cyclooxygenase and the lipoxygenase pathways in a time-dependent fashion. Comparing tumors grown in cPLA2 knockout vs wild-type mice, we demonstrated that prostaglandins (PGE2, PGD2 and PGF2a) were produced by both cancer cells and the tumor microenvironment (TME), but leukotriene (LTB4, LTC4, LTD4, LTE4) production required cPLA2 expression in the TME. Using flow cytometry, we recovered tumor-associated neutrophils and 2 types of tumor-associated macrophages from tumor-bearing lungs and we defined their distinct eicosanoid profiles by LC/MS/MS. The combination of flow cytometry and LC/MS/MS unravels the complexity of eicosanoid production in lung cancer and provides a rationale to develop therapeutic strategies that target select cell populations to inhibit specific classes of eicosanoids.http://europepmc.org/articles/PMC3823604?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joanna M Poczobutt Miguel Gijon Jay Amin Dwight Hanson Howard Li Deandra Walker Mary Weiser-Evans Xian Lu Robert C Murphy Raphael A Nemenoff |
spellingShingle |
Joanna M Poczobutt Miguel Gijon Jay Amin Dwight Hanson Howard Li Deandra Walker Mary Weiser-Evans Xian Lu Robert C Murphy Raphael A Nemenoff Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. PLoS ONE |
author_facet |
Joanna M Poczobutt Miguel Gijon Jay Amin Dwight Hanson Howard Li Deandra Walker Mary Weiser-Evans Xian Lu Robert C Murphy Raphael A Nemenoff |
author_sort |
Joanna M Poczobutt |
title |
Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. |
title_short |
Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. |
title_full |
Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. |
title_fullStr |
Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. |
title_full_unstemmed |
Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. |
title_sort |
eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
Eicosanoids are bioactive lipid mediators derived from arachidonic acid(1) (AA), which is released by cytosolic phospholipase A2 (cPLA2). AA is metabolized through three major pathways, cyclooxygenase (COX), lipoxygenase (LO) and cytochrome P450, to produce a family of eicosanoids, which individually have been shown to have pro- or anti-tumorigenic activities in cancer. However, cancer progression likely depends on complex changes in multiple eicosanoids produced by cancer cells and by tumor microenvironment and a systematic examination of the spectrum of eicosanoids in cancer has not been performed. We used liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) to quantitate eicosanoids produced during lung tumor progression in an orthotopic immunocompetent mouse model of lung cancer, in which Lewis lung carcinoma (LLC) cells are injected into lungs of syngeneic mice. The presence of tumor increased products of both the cyclooxygenase and the lipoxygenase pathways in a time-dependent fashion. Comparing tumors grown in cPLA2 knockout vs wild-type mice, we demonstrated that prostaglandins (PGE2, PGD2 and PGF2a) were produced by both cancer cells and the tumor microenvironment (TME), but leukotriene (LTB4, LTC4, LTD4, LTE4) production required cPLA2 expression in the TME. Using flow cytometry, we recovered tumor-associated neutrophils and 2 types of tumor-associated macrophages from tumor-bearing lungs and we defined their distinct eicosanoid profiles by LC/MS/MS. The combination of flow cytometry and LC/MS/MS unravels the complexity of eicosanoid production in lung cancer and provides a rationale to develop therapeutic strategies that target select cell populations to inhibit specific classes of eicosanoids. |
url |
http://europepmc.org/articles/PMC3823604?pdf=render |
work_keys_str_mv |
AT joannampoczobutt eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT miguelgijon eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT jayamin eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT dwighthanson eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT howardli eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT deandrawalker eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT maryweiserevans eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT xianlu eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT robertcmurphy eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment AT raphaelanemenoff eicosanoidprofilinginanorthotopicmodeloflungcancerprogressionbymassspectrometrydemonstratesselectiveproductionofleukotrienesbyinflammatorycellsofthemicroenvironment |
_version_ |
1725017121621016576 |